Synovus Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-20
Closed -$1K 839
2020
Q2
$1K Sell
20
-230
-92% -$11.5K ﹤0.01% 1474
2020
Q1
$11K Buy
+250
New +$11K ﹤0.01% 1521
2019
Q4
Sell
-500
Closed -$20K 1555
2019
Q3
$20K Hold
500
﹤0.01% 1086
2019
Q2
$24K Hold
500
﹤0.01% 984
2019
Q1
$18K Hold
500
﹤0.01% 1023
2018
Q4
$14K Hold
500
﹤0.01% 1027
2018
Q3
$22K Buy
+500
New +$22K ﹤0.01% 1003